David Baker
- Neurology top 0.2%
- Neuroinflammation and Neurodegeneration Mechanisms 24
- Pathology and Forensic Medicine top 0.1%
- Multiple Sclerosis Research Studies 94
- Pharmacology top 0.1%
- Cannabis and Cannabinoid Research 39
- Developmental Neuroscience top 0.5%
- Biological Psychiatry top 1%
-
- Immunotherapy and Immune Responses 34
- T-cell and B-cell Immunology 28
-
- Neuroscience and Neuropharmacology Research 26
-
- Polyomavirus and related diseases 20
-
- Monoclonal and Polyclonal Antibodies Research 20
- Co-authors
- Gareth PryceSandra AmorGavin GiovannoniPaul van der ValkFabìola PuentesKlaus SchmiererJ.K. O'NeillJ.L. Turk
- Journals
- Multiple Sclerosis and Related Disorders (31 papers)Journal of Neuroimmunology (21 papers)Multiple Sclerosis Journal (9 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
David Baker
288 papers receiving 15.1k citations
Hit Papers
Peers
Comparison fields: 5 of 179
- Neurology 2.1k
- Pathology and Forensic Medicine 3.6k
- Pharmacology 3.3k
- Developmental Neuroscience 701
- Biological Psychiatry 394
Countries citing papers authored by David Baker
This map shows the geographic impact of David Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Baker more than expected).
Fields of papers citing papers by David Baker
This network shows the impact of papers produced by David Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Baker. The network helps show where David Baker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 0 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 1 | |
| 9 | 2019 | 30 | |
| 10 | 2013 | 9 | |
| 11 | Selective targeting of neuroprotection to MS lesions: sodium channel blockers in experimental autoimmune encephalomyelitis | 2011 | 1 |
| 12 | Neuroprotection in a novel optic neuritis model | 2011 | 1 |
| 13 | Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolismbreakdown → | 2009 | 565 |
| 14 | 2009 | 48 | |
| 15 | 2006 | 80 | |
| 16 | 2005 | 59 | |
| 17 | 2003 | 6 | |
| 18 | 2003 | 10 | |
| 19 | 2002 | 96 | |
| 20 | Central nervous system gene therapy for experimental allergic encephalomyelitis | 1999 | 1 |
About David Baker
David Baker is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology, having authored 296 papers that have together received 15.4k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (94 papers), Cannabis and Cannabinoid Research (39 papers), Immunotherapy and Immune Responses (34 papers), T-cell and B-cell Immunology (28 papers), Neuroscience and Neuropharmacology Research (26 papers), Neuroinflammation and Neurodegeneration Mechanisms (24 papers), Polyomavirus and related diseases (20 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). The work is most often cited by research in Neurology (2.1k citations), Pathology and Forensic Medicine (3.6k citations) and Pharmacology (3.3k citations). David Baker has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Gareth Pryce, Sandra Amor, Gavin Giovannoni, Paul van der Valk, Fabìola Puentes, Klaus Schmierer, J.K. O'Neill, J.L. Turk, Jeremy K. Nicholson and T. Andrew Clayton. Their work appears in journals such as Multiple Sclerosis and Related Disorders, Journal of Neuroimmunology, Multiple Sclerosis Journal, Immunology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.